Eagle Pharmaceuticals, Inc. ( EGRX) - Stock Earnings
EGRX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | 8.2 million USD | 60.7 million USD |
| 2023Q1 | 5.8 million USD | 66.3 million USD |
| 2023Q2 | 5.2 million USD | 64.6 million USD |
EGRX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2020 | 12.0 million USD | 187.8 million USD |
| 2021 | -8.6 million USD | 171.5 million USD |
| 2022 | 35.6 million USD | 316.6 million USD |
EGRX
Price: $0.60
52 week price:
Earnings Per Share: 0.07 USD
P/E Ratio: 2.14
Exchange: OEM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 130600
Ebitda: 25.9 millionMarket Capitalization: 8.6 million